Kiran Mazumdar Shaw, born in 1953 in Bangalore, is the founder of Biocon Ltd., India's largest biotechnology company, which she started in 1978 with a mere capital of Rs. 10,000. She faced numerous challenges including funding, technology, and gender bias but successfully expanded Biocon into a biopharmaceutical powerhouse, achieving landmark milestones such as the development of human insulin and a successful IPO in 2004. Recognized for her contributions to science and business, she has received several awards and honors, including the Padma Shri and Padma Bhushan, and has been listed among the most influential people and powerful women globally.

1. Kiran muzumdar shaw
Prepared by saikrushna guntapelliwar
(saikrushnaguntapelliwar@gmail.com)

2. Born on 23rd march in 1953 in Bangalore .
Schooling at Bishop Cotton Girls School & Mount
Carmel College at Bangalore .
B.Sc in Zoology from Bangalore University .
Qualified as a master brewer from Ballarat
University, Australia .
CMD, Biocon Ltd., India’s biggest Biotechnology
Company .
In 2004, she became India’s Richest Woman .

3. Kiran Mazumdar Shaw is married to John Shaw, a
Scotsman and Indophile.
John Shaw headed a leading textiles MNC, Madura
Coats from 1991 to 1998 as CMD.
Currently, John Shaw is Vice-Chairman of Biocon,
Ltd.

4.  In 1978, joined Biocon Biochemical Limited, of Cork,
Ireland as a Trainee Manager
 In 1978 itself, started Biocon in garage in Bangalore with
a capital of Rs. 10,000.
 Within a year, Biocon became the first Indian company to
manufacture and export enzymes to USA and Europe
 In 1990, upgraded Biocon’s in-house research program,
based on a proprietary solid substrate fermentation
technology.
 The commercial success of this program led to a three-
fold expansion by 1996 and Biocon entered the
biopharmaceuticals and statins segments

5.  In 1998, Biocon became an independent entity.
 In 2000, Biocon's proprietary bioreactor, christened
PlafractorTM, based on solid matrix fermentation
received a U.S. patent.
 By 2003 Biocon became the first company worldwide to
develop human insulin on a Pichia expression system.
 In 2004, to access the capital markets to develop
Biocon’s pipeline of research programs .
 Biocon’s IPO was oversubscribed 32 times and its first
day at the bourses closed with a market value of $1.11
billion.
 It made Biocon the 2nd only company to cross $1 billion
mark on the first day of listing.
 Entered into more than 2,200 high-value R&D licensing
and other deals within the pharmaceuticals and bio-
pharmaceutical space between 2005 & 2010 .

6. Med Ad News, in its 2007/08 listings has ranked
Biocon 20th amongst the leading biotechnology
companies in the world.
Biocon also recently received the 2009 BioSingapore
Asia Pacific Biotechnology Award for Best Listed
Company .
Med Ad News, in its 2007/08 listings also ranked
Biocon as 7th Largest Employer in the world.

7. Indian laws restricted foreign ownership to 30% of
the company. The remaining 70% belonged to
Kiran Mazumdar.
 faced credibility challenges :because of her youth,
gender and her untested business model.
Funding was a problem.
Uninterrupted power, superior quality water, sterile
labs.
 imported research equipment, and workers with
advanced scientific skills were not easily available .

8. Difficult to recruit people : to work for her start-
up. Her first employee was a retired garage
mechanic.
Faced the technological challenges associated with
trying to build a biotech business in a country with
a shaky infrastructure.

9. Affordable innovation .
Continuous concentration on research and
development.
Identifying the need for affordable drugs less
wealthy countries and looked for opportunities to
develop cost effective techniques.
Notice the market potential and do work on that .

10. Independence:
Preference for Limited Structure:
Risk Acceptance:
Passion:
Future Focus:
Execution:
Optimism:
 Interpersonal Sensitivity:

11.  TIME magazine’s 100 most influential people in the
world.
 2011 Financial Times’ top 50 women in business list.
 2014, the 92nd most powerful woman in the world by
Forbes.
 the Othmer Gold Medal (2014) for outstanding
contributions to the progress of science and chemistry,
 the Nikkei Asia Prize (2009) for Regional Growth, the
‘Veuve Clicquot Initiative For Economic Development For
Asia' Award (2007),

12.  Ernst & Young Entrepreneur of the Year Award for
Life Sciences & Healthcare (2002), and 'Technology
Pioneer' recognition by World Economic Forum
(2002).
Padma Shri (1989) and the Padma Bhushan (2005)
from the government of India.
She was given the Economic Times Award for
'Businesswoman of the Year' in 2004.
 At the Pharmaleaders Pharmaceutical Leadership
Summit she was named "Global Indian Woman of
the Year" (2012) she also received the Express
Pharmaceutical Leadership Summit Award for
"Dynamic Entrepreneur" in 2009.

13.  Kay learning from Mrs. Kiran muzumdar Shaw
 Leadership qualities .
 Face the challenges .
 The ability to motivate employees at various levels.
 It is essential for the leader to emphasis the importance
of ethics to the employees -- new and old on an ongoing
basis.
 How to become a better leader not a boss .
 Why personal branding is important for a entrepreneur .
 leadership by demonstrating the importance of
acknowledging the efforts of the entire sales force
irrespective of whether they met their targets. It brings
in team spirit and a collective celebration of success.